OSSTEC

OSSTEC

OSSTEC's aims to empower people to be the best they can be.

HQ location
London, United Kingdom
Website
Launch date
Employees
Enterprise value
$13—20m
Company register number
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor investor investor investor investor investor

€0.0

round
*

£2.5m

Seed
Total Funding000k
More about OSSTEC
Made with AI
Edit

OSSTEC is a pioneering MedTech startup focused on revolutionizing knee replacement surgery through advanced 3D printing and biomimetic (nature-inspired) implants. The company operates in the orthopedic medical device market, primarily targeting patients who require partial knee replacements. This market is significant, with 1.3 million knee replacement surgeries performed globally each year, and a growing number of younger patients undergoing these procedures.

OSSTEC's innovative approach centers on developing cementless partial knee implants. Traditional implants often fail due to loosening between the implant and bone, particularly in younger patients. OSSTEC's cementless implants reduce this risk by 50%, offering long-term biological fixation without the need for cement, which can degrade over time. This results in better patient outcomes, faster recovery times, and overall cost-effectiveness.

The company's business model is built around the commercialization of its proprietary bone healing platform technology. After nearly a decade of research and development, OSSTEC has unveiled its first product and is actively expanding its market reach. The startup generates revenue through the sale of its advanced knee implants to hospitals and orthopedic surgeons. Additionally, OSSTEC benefits from strategic investments and funding rounds, which have enabled the company to grow its team and accelerate technological advancements.

In 2023, OSSTEC successfully closed an oversubscribed funding round, attracting support from notable investors such as SFC, Parkwalk Advisors, and Embryo Ventures. This financial boost has been instrumental in transitioning the company from the research lab to the operating room, allowing for significant team expansion and product development.

Looking ahead, OSSTEC is poised for a transformative 2024, with plans to further penetrate the market and enhance its product offerings. The company's commitment to improving patient outcomes and advancing orthopedic technology positions it as a key player in the MedTech industry.

Keywords: MedTech, knee replacement, 3D printing, biomimetic implants, orthopedic, cementless implants, patient outcomes, funding, innovation, healthcare.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads